Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Clinical pharmacokinetics of lofexidine, the alpha 2-adrenergic receptor agonist, in opiate addicts plasma using a highly sensitive liquid chromatography tandem mass spectrometric analysis.

Yu E, Miotto K, Akerele E, O'Brien CP, Ling W, Kleber H, Fischman MW, Elkashef A, Herman BH, Al-Ghananeem AM.

Am J Drug Alcohol Abuse. 2008;34(5):611-6. doi: 10.1080/00952990802308122.

PMID:
18821454
2.

Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.

Gish EC, Miller JL, Honey BL, Johnson PN.

Ann Pharmacother. 2010 Feb;44(2):343-51. doi: 10.1345/aph.1M347. Epub 2009 Dec 29. Review.

PMID:
20040696
3.

Alpha2-adrenergic agonists in opioid withdrawal.

Gowing LR, Farrell M, Ali RL, White JM.

Addiction. 2002 Jan;97(1):49-58. Review.

PMID:
11895270
4.

Lofexidine for opiate detoxification: review of recent randomised and open controlled trials.

Strang J, Bearn J, Gossop M.

Am J Addict. 1999 Fall;8(4):337-48. Review.

PMID:
10598217
5.

Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients.

Honey BL, Benefield RJ, Miller JL, Johnson PN.

Ann Pharmacother. 2009 Sep;43(9):1506-11. doi: 10.1345/aph.1M161. Epub 2009 Aug 18. Review.

PMID:
19690220
6.

Clonidine.

Roehrich H, Gold MS.

Adv Alcohol Subst Abuse. 1987;7(1):1-16. Review.

PMID:
3327371
7.

[Mechanisms of pharmacological activity alpha-adrenergic agonists in treatment of opiate drug dependence].

Golovko AI, Golovko SI, Zefirov SIu, Kirakosian AV, Konoplin DA, Nekrasov IuA, Romanenko OI, Strel'skiń≠ MA.

Eksp Klin Farmakol. 2001 Jan-Feb;64(1):77-80. Review. Russian. No abstract available.

PMID:
11544814

Supplemental Content

Support Center